EyePoint Pharmaceuticals Reports First Quarter 2022 Financial Results and Highlights Recent Corporate Developments
– Presented positive eight-month safety and efficacy data from ongoing DAVIO Phase 1 clinical trial…
News
Mindset Pharma to Participate in Upcoming Conferences in May 2022
TORONTO, May 04, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
Genenta Progresses to Higher Dosing Cohort in Temferon™ Phase 1/2a Clinical Trial in Glioblastoma Multiforme
No dose limiting toxicity observed in previous three dose level cohortsRepresents a 50% higher dose…
Aptose Receives Fast Track Designation for HM43239 in Relapsed/Refractory AML Patients and FLT3 Mutation
SAN DIEGO and TORONTO, May 04, 2022 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or…
Abeona Therapeutics Announces AAV204, a Novel AAV Capsid, Demonstrated Robust Macular Transduction Following Para-Retinal Administration in Non-Human Primates
NEW YORK and CLEVELAND, Ohio, May 04, 2022 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq:…
Diffusion Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
CHARLOTTESVILLE, Va., May 04, 2022 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or…
Harvard Bioscience Announces First Quarter 2022 Financial Results
• Revenue up 7% year-over-year despite volatility in China related to COVID-19 and global…
Akouos to Present at Bank of America 2022 Healthcare Conference
BOSTON, May 04, 2022 (GLOBE NEWSWIRE) — Akouos, Inc. (“Akouos”) (NASDAQ: AKUS), a precision genetic…
Oncorus Reports First Quarter 2022 Financial Results and Provides Business Updates
Additional clinical data from ONCR-177 surface lesion monotherapy expansion and combination expansion cohorts expected in…
ADMA Biologics to Report First Quarter 2022 Financial Results on May 11, 2022
Conference Call Scheduled for May 11, 2022 at 4:30 p.m. ET RAMSEY, N.J. and BOCA…
Amicus Therapeutics to Present at the Bank of America 2022 Healthcare Conference
PHILADELPHIA, May 04, 2022 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that management…
EyePoint Pharmaceuticals Announces Expanded License Agreement with Betta Pharmaceuticals for EYP-1901 in China, Hong Kong, Macau and Taiwan
– Betta Pharmaceuticals to develop and commercialize EYP-1901 in China, Hong Kong, Macau and Taiwan;…
Amarin Reports First Quarter 2022 Financial Results and Provides Business Update
Initiated Next Phase of European Expansion Strategy with First National Reimbursement in Sweden Market Access…
Oncotelic Appoints Seymour Fein M.D. as Chief Regulatory Officer
AGOURA HILLS, Calif., May 04, 2022 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic” or the…
Editas Medicine Announces First Quarter 2022 Results and Business Updates
Appointed Gilmore O’Neill as CEO effective June 1, 2022; James C. Mullen to serve as…
G1 Therapeutics Provides First Quarter 2022 Financial Results and Operational Highlights
– Achieved $6.9 Million in Total Revenue in the First Quarter of 2022, Including $5.5…
Applied Awarded Gold and Silver Stevie® Awards in 2022 American Business Awards
Company recognized for its innovation and excellence in the workplace UNIVERSITY PARK, Ill., May 04,…
Exterro Enhances Digital Forensic and Incident Response Automation with Major Upgrades to FTK® Connect
Enhanced FTK Connect adds power and speed to FTK® solutions with new automation, integration and…
Fortinet Enhances the Industry’s Only True Converged Networking and Security Platform with New Suite of FortiGate Network Firewalls
FortiGate serves as the foundation of the industry’s most comprehensive converged platform, powered by custom…
TRON Announces its Collaboration and Investment Initiatives in Suriname
Geneva, Switzerland–(Newsfile Corp. – May 4, 2022) – TRON has announced its intentions to explore…